Insulin gene polymorphisms in type I diabetes, Addison's disease and the polyglandular autoimmune syndrome type II
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: BMC medical genetics, 9.2008, Art. 65, doi:10.1186/1471-2350-9-65
- Schlagwort
-
Endokrinologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2008
- Urheber
-
Ramos-Lopez, Elizabeth
Lange, Britta Kristina
Kahles, Heinrich
Willenberg, Holger S.
Meyer, Gesine
Penna Martinez, Marissa
Reisch, Nicole
Hahner, Stefanie
Seissler, Jürgen
Badenhoop, Klaus
- URN
-
urn:nbn:de:hebis:30-57530
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ramos-Lopez, Elizabeth
- Lange, Britta Kristina
- Kahles, Heinrich
- Willenberg, Holger S.
- Meyer, Gesine
- Penna Martinez, Marissa
- Reisch, Nicole
- Hahner, Stefanie
- Seissler, Jürgen
- Badenhoop, Klaus
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2008
Ähnliche Objekte (12)
Receptor repertoire of the autoimmune response in type 1 diabetes
Insulin, sulphonylurea : combination therapy in type II diabetes
CTLA-4 as a genetic determinant in autoimmune Addison's disease
CXCL4L1 promoter polymorphisms are associated with improved renal function in Type 1 Diabetes
Association between immune reactivity and disease status of type 1, type 2 diabetes and latent autoimmune diabetes in adults
The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases
Impaired insulin turnover in islets from type 2 diabetic patients
Insulin Binding to Erythrocytes in Children with Type-I Diabetes mellitus
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial
How patients with insulin-treated type 1 and type 2 diabetes view their own and their physician's treatment goals
Olfactory dysfunction after autoimmune encephalitis depending on the antibody type and limbic MRI pathologies
Induction of type 1 diabetes using preproinsulin-based vaccines in Experimental Autoimmune Diabetes (EAD)
Receptor repertoire of the autoimmune response in type 1 diabetes
Insulin, sulphonylurea : combination therapy in type II diabetes
CTLA-4 as a genetic determinant in autoimmune Addison's disease
CXCL4L1 promoter polymorphisms are associated with improved renal function in Type 1 Diabetes
Association between immune reactivity and disease status of type 1, type 2 diabetes and latent autoimmune diabetes in adults
The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases
Impaired insulin turnover in islets from type 2 diabetic patients
Insulin Binding to Erythrocytes in Children with Type-I Diabetes mellitus
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial
How patients with insulin-treated type 1 and type 2 diabetes view their own and their physician's treatment goals
Olfactory dysfunction after autoimmune encephalitis depending on the antibody type and limbic MRI pathologies
Induction of type 1 diabetes using preproinsulin-based vaccines in Experimental Autoimmune Diabetes (EAD)
Receptor repertoire of the autoimmune response in type 1 diabetes
Insulin, sulphonylurea : combination therapy in type II diabetes
CTLA-4 as a genetic determinant in autoimmune Addison's disease
CXCL4L1 promoter polymorphisms are associated with improved renal function in Type 1 Diabetes
Association between immune reactivity and disease status of type 1, type 2 diabetes and latent autoimmune diabetes in adults
The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases
Impaired insulin turnover in islets from type 2 diabetic patients
Insulin Binding to Erythrocytes in Children with Type-I Diabetes mellitus
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial
How patients with insulin-treated type 1 and type 2 diabetes view their own and their physician's treatment goals
Olfactory dysfunction after autoimmune encephalitis depending on the antibody type and limbic MRI pathologies